Nike Earnings Preview: What Will Prove The Turnaround?

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

This Nike earnings preview begins with Nike reporting fiscal first-quarter 2027 results on October 1 after the close, and Wall Street is heading into the print with expectations already reset sharply lower. Consensus is around $11.35 billion of revenue and roughly $0.44 of EPS, while management itself has guided revenue down low-to-mid single digits and expects only slight gross-margin expansion. The obvious debate is whether Elliott Hill’s turnaround is finally beginning to show through the numbers: Running is growing again, football had a powerful World Cup moment, wholesale relationships are improving, and markdown pressure appears to be stabilizing.

But the more important question may sit outside the income statement. Kylian Mbappé’s decision to leave Nike for On is an unusually visible reminder that Nike is trying to rebuild more than revenue growth — it is trying to rebuild its gravitational pull with athletes, consumers and culture. That makes this quarter awkwardly timed. Nike can show progress now, but the company itself says the first full Sport Offense product cycle does not arrive until Spring 2027. Thursday therefore looks less like a verdict and more like a credibility test for the next two quarters.

The Priced-In Scenario

Wall Street is not expecting a clean growth quarter. Management told investors after fiscal Q4 that first-quarter revenue should decline low-to-mid single digits, with no foreign-exchange benefit, while gross margin should turn slightly positive year over year. SG&A dollars are expected to remain roughly flat even as demand creation rises high single digits around the World Cup, meaning the basic earnings setup already assumes that Nike continues spending behind sport while trying to recover profitability elsewhere.

That is important because the last quarter contained a major accounting distortion. Nike reported Q4 EPS of $0.72, but excluding the tariff-recovery benefit, EPS was only $0.20. For the full year, reported EPS was $2.10 versus $1.58 excluding that benefit, so investors already know the headline earnings number can say less about the underlying business than it first appears.

The narrative Wall Street is effectively modeling is more nuanced: performance categories keep improving, gross margin slowly recovers, but Sportswear, Jordan Streetwear and China remain large enough to keep total revenue under pressure. That is broadly consistent with Nike’s own commentary. Running had delivered five consecutive quarters of double-digit growth, added...

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

CVR Energy Acquisition: $4 Billion Marathon Refinery Deal?

CVR Energy (NYSE:CVI) may be approaching a pivotal expansion....

TOYO: Customs Clearance & $357M Texas Expansion

TOYO Co., Ltd. (NASDAQ: TOYO) has received a potentially...

Marvell Lumentum Acquisition: $83 Billion AI Optics Deal?

Marvell Technology Inc. (NASDAQ: MARVL) is reportedly approaching one...

Vertiv UIG Acquisition: $2.6 Billion AI Power Expansion

Vertiv Holdings Co. (NYSE:VRT) has completed its acquisition of...

EQT Range Acquisition: $625M Synergies & Valuation Risks

EQT Corporation (NYSE:EQT) has announced a $12.8 billion all-stock...

Related Articles

CVR Energy Acquisition: $4 Billion Marathon Refinery Deal?

CVR Energy (NYSE:CVI) may be approaching a pivotal expansion....

TOYO: Customs Clearance & $357M Texas Expansion

TOYO Co., Ltd. (NASDAQ: TOYO) has received a potentially...

Marvell Lumentum Acquisition: $83 Billion AI Optics Deal?

Marvell Technology Inc. (NASDAQ: MARVL) is reportedly approaching one...

Vertiv UIG Acquisition: $2.6 Billion AI Power Expansion

Vertiv Holdings Co. (NYSE:VRT) has completed its acquisition of...

EQT Range Acquisition: $625M Synergies & Valuation Risks

EQT Corporation (NYSE:EQT) has announced a $12.8 billion all-stock...

Elbit Systems Stock: $200M Deal, $32B Backlog, Valuation Risks

Elbit Systems (NASDAQ:ESLT) has secured approximately $200 million in...

Moderna Cancer Vaccine: Why Shares Crashed 18%

Imagine a company reporting encouraging cancer treatment results, only...

Intel Terafab Plans: 14A Progress Meets Valuation Risk

Intel (NASDAQ:INTC) has found itself at the center of...
spot_img

Related Articles

Popular Categories

spot_imgspot_img